Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
AstraZeneca
University Health Network, Toronto
St. Olavs Hospital
MediLink Therapeutics (Suzhou) Co., Ltd.
University of California, San Diego
Karyopharm Therapeutics Inc
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.